Premium
Moleculin Biotech Inc (MBRX)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Mod... Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0182 | 1.59649122807 | 1.14 | 1.17 | 0.9945 | 535084 | 1.07365975 | CS |
| 4 | -0.4068 | -25.9936102236 | 1.565 | 1.64 | 0.9412 | 3184238 | 1.25636167 | CS |
| 12 | -0.7318 | -38.7195767196 | 1.89 | 3.6499 | 0.3975 | 6171065 | 1.64445998 | CS |
| 26 | -1.4918 | -56.2943396226 | 2.65 | 3.6499 | 0.3975 | 2785841 | 1.65219475 | CS |
| 52 | -4.8418 | -80.6966666667 | 6 | 6.2348 | 0.3975 | 1396242 | 1.6843047 | CS |
| 156 | -25.6918 | -95.686405959 | 26.85 | 30.75 | 0.3975 | 555399 | 3.61005608 | CS |
| 260 | -8.4418 | -87.9354166667 | 9.6 | 131.7 | 0.3975 | 1118737 | 21.9146818 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
